Bioprocessing Summit US 2026
Date: August 10-13, 2026
Location: Omni Boston Hotel at the Seaport Boston, Massachusetts
JOIN US!
Meet with Catalent’s biologics experts to discuss integrated drug substance and drug product solutions designed to help accelerate development, scale-up, and commercial manufacturing. Join our presentation to learn how GPEx® Lightning, a flexible cell line development platform can enable faster progression from transient expression to stable pool production for complex biologics.
Complete the form to schedule a meeting with our experts!
SPEAKING ENGAGEMENTS!
Speaker: Chad Hall, PhD, Principal Scientist, R&D, Catalent
Date/Time: 12:45-1:15 PM ET, August 11, 2026
Title: A Simple and Tunable Expression Platform for Rapid Transient-to-Stable Pool Production of Complex Biologics
ABOUT CATALENT
Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that Catalent helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. Catalent provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. Catalent tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.
